4//SEC Filing
Crowley John F 4
Accession 0000950170-24-017264
CIK 0001178879other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:23 PM ET
Size
7.2 KB
Accession
0000950170-24-017264
Insider Transaction Report
Form 4
Crowley John F
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-02-15$13.81/sh−31,614$436,551→ 697,628 total - Tax Payment
Common Stock
2024-02-15$14.00/sh−94,969$1,329,566→ 602,659 total
Holdings
- 64,895(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.36 to $14.02 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001400973
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 5:23 PM ET
- Size
- 7.2 KB